1-1 of 1
Brian Middleton
Close
Sort by
Journal Articles

The Novel HDAC Inhibitor UCL67022 Is Highly Potent in Multiple Myeloma and Non-Hodgkin’s Lymphoma and Is Enhanced by Bortezomib.

Lenushka Maharaj, Rakesh Popat, Angela Chahwan, Andrew T. Lister, James D. Cavenagh, Brian Middleton, Alf Rioja, Charles Marson, Simon P. Joel
Journal: Blood
Blood (2006) 108 (11): 2604.
https://doi.org/10.1182/blood.V108.11.2604.2604
Published: 2006